Bluebird Bio's Key Decisions and Shareholder Engagement in 2024

TipRanksNov 7 06:02

Express News | Bluebird bio Adjourns Meeting of Stockholders and Announces Third Quarter Results Call

BreakingsNov 7 05:15

Bluebird Bio Adjourns Meeting of Stockholders and Announces Third Quarter Results Call

BusinesswireNov 7 05:15

Bluebird Bio To Present Additional Long-Term Follow-up Data From Gene Therapy Programs In Sickle Cell Disease And Beta-Thalassemia At The 66th ASH Annual Meeting and Exposition

BenzingaNov 5 22:19

Worries Mount Over Cancer Risks in Bluebird Bio's Gene Therapy

BenzingaOct 11 21:09

7 Children Given Bluebird's Skysona Developed Blood Cancer: Study

Seeking AlphaOct 11 04:56